Premium
Novel Diketopiperazine Dihydroorotate Dehydrogenase Inhibitors Purified from Traditional Tibetan Animal Medicine Osteon Myospalacem Baileyi
Author(s) -
Jiang Lei,
Wen Huaixiu,
Shao Yun,
Yu Ruitao,
Liu Zenggen,
Wang Shuo,
Wang Qilan,
Zhao Xiaohui,
Zhang Peng,
Tao Yanduo,
Mei Lijuan
Publication year - 2015
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12530
Subject(s) - dihydroorotate dehydrogenase , stereochemistry , dehydrogenase , enzyme , chemistry , biochemistry
Traditional Tibetan medicine provides an abundant source of knowledge on human ailments and their treatment. As such, it is necessary to explore their active single compounds used to treat these ailments to discover lead compounds with good pharmacologic properties. In this present work, animal medicine, Osteon Myospalacem Baileyi extracts have been separated using a two‐dimensional preparative chromatographic method to obtain single compounds with high purity as part of the following pharmacological research. Five high‐purity cyclic dipeptides from chromatography work were studied for their dihydroorotate dehydrogenase inhibitory activity on recombinant human dihydroorotate dehydrogenase enzyme and compound Fr. 1‐4 was found to contain satisfying inhibition activity. The molecular modeling study suggests that the active compound Fr. 1‐4 may have a teriflunomide‐like binding mode. Then, the energy decomposition study suggests that the hydrogen bond between Fr. 1‐4 and Arg136 can improve the binding mode to indirectly increase the van der Waals binding energy. All the results above together come to the conclusion that the 2, 5‐diketopiperazine structure group can interact with the polar residues well in the active pocket using electrostatic power. If some proper hydrophobic groups can be added to the sides of the 2, 5‐diketopiperazine group, it is believed that better 2, 5‐diketopiperazine dihydroorotate dehydrogenase inhibitors will be found in the future.